Literature DB >> 31187256

Incidence and risk factors for heterotopic ossification following periprosthetic joint infection of the hip.

Thomas Rosteius1, Valentin Rausch2, Simon Pätzholz3, Sebastian Lotzien2, Hinnerk Baecker2, Thomas Armin Schildhauer2, Jan Geßmann2.   

Abstract

INTRODUCTION: Heterotopic ossifications (HOs) commonly occur following total hip arthroplasty. Data regarding the appearance of HO after periprosthetic joint infection (PJI) of the hip are rare. Therefore, the aim of this study was to analyze the incidence and potential risk factors for the development of HO in patients with PJI of the hip.
MATERIALS AND METHODS: We performed a single-center, retrospective study including patients treated with a two- or multistage operation and patients undergoing salvage procedure in cases of PJI of the hip with a minimum follow-up of 6 months. A total of 150 patients were included in the analysis. The Brooker-scale was used to classify HO. Patients were divided in three groups: (1) No HO, (2) HO Brooker type 1-4, and (3) high-grade HO (HO Brooker type 3 and 4). In each group, we checked possible risk factors for the development of HO for statistical significance.
RESULTS: Patients included in our study had a mean age of 70.4 ± 12.1 years. Of all patients, 75 were women (50%). HOs could be found in 70 patients (46.7%). Twenty-seven patients showed HO Brooker type 1, 23 type 2, 15 type 3 and 5 type 4. Male gender [odds ratio (OR) 2.14; p = 0.022], smoking (OR 5.75; p = 0.025) were significant risk factors for HO. A chronic infection (OR 3.54; p = 0.029) and a higher number of procedures (p = 0.009) were significant risk factors for the development of high-grade HO.
CONCLUSIONS: HOs often occur following surgical care of PJI. Male gender, smoking, a chronic infection and high number of operations are risk factors for developing HO after PJI.

Entities:  

Keywords:  Heterotopic ossification; Periprosthetic joint infection; Revision hip arthroplasty; Risk factors; Total hip arthroplasty

Mesh:

Year:  2019        PMID: 31187256     DOI: 10.1007/s00402-019-03215-6

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  6 in total

1.  Are there really specific risk factors for heterotopic ossifications? A case report of 'non-risk factor' after total hip replacement.

Authors:  Tomasz Stołtny; Jarosław Pasek; Dominika Rokicka; Marta Wróbel; Michał Dobrakowski; Paweł Kamiński; Rafał Domagalski; Szymon Czech; Krzysztof Strojek; Bogdan Koczy
Journal:  J Int Med Res       Date:  2022-06       Impact factor: 1.573

2.  How Can We Differentiate Local Recurrence From Heterotopic Ossification After Resection and Implantation of an Oncologic Knee Prosthesis in Patients with a Bone Sarcoma?

Authors:  Khodamorad Jamshidi; Abolfazl Bagherifard; Hamadalla Hadi Al-Baseesee; Alireza Mirzaei
Journal:  Clin Orthop Relat Res       Date:  2021-05-01       Impact factor: 4.176

3.  Heterotopic ossification in primary total hip arthroplasty using the posterolateral compared to the direct lateral approach.

Authors:  J H J van Erp; J R A Massier; S Truijen; J E J Bekkers; T E Snijders; A de Gast
Journal:  Arch Orthop Trauma Surg       Date:  2021-02-03       Impact factor: 3.067

4.  Heterotopic Ossification in Orthopaedic and Trauma surgery: A Histopathological Ossification Score.

Authors:  M Ohlmeier; V Krenn; D M Thiesen; N A Sandiford; T Gehrke; M Citak
Journal:  Sci Rep       Date:  2019-12-05       Impact factor: 4.379

Review 5.  Radiological changes, infections and neurological complications after reverse shoulder arthroplasty related to different design types and their rates: Part II.

Authors:  Marko Nabergoj; Patrick J Denard; Philippe Collin; Rihard Trebše; Alexandre Lädermann
Journal:  EFORT Open Rev       Date:  2021-11-19

6.  A Rare Case of Extremely Severe Heterotopic Ossification after Primary Total Hip Arthroplasty due to Persistent Mild Periprosthetic Joint Infection.

Authors:  Yutaka Kinoshita; Shunji Nakano; Shinji Yoshioka; Masaru Nakamura; Tomohiro Goto; Daisuke Hamada; Koichi Sairyo
Journal:  Case Rep Orthop       Date:  2021-05-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.